{
    "Trade/Device Name(s)": [
        "BGM009 Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Apex Biotechnology Corp.",
    "510(k) Number": "K141036",
    "Predicate Device Reference 510(k) Number(s)": [
        "K113208"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "April 22, 2015",
    "Summary Letter Received Date": "April 23, 2015",
    "Submission Date": "September 10, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BGM009 blood glucose meter"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Meter"
    ],
    "Document Summary": "FDA 510(k) summary for Apex Biotechnology Corp. BGM009 Blood Glucose Monitoring System for quantitative measurement of blood glucose",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips, forearm, or palm for self-testing by diabetic patients at home, not for diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}